风华高科(000636) - 2022 Q3 - 季度财报

Revenue and Profit - Revenue for Q3 2022 was ¥800,745,660.83, a decrease of 36.35% compared to the same period last year[7] - Net profit attributable to shareholders was -¥55,259,533.74, a decline of 114.79% year-over-year[7] - The net profit after deducting non-recurring gains and losses was -¥66,311,316.07, down 127.46% from the previous year[7] - Total operating revenue for Q3 2022 was CNY 2,918,894,480.95, a decrease of 26.2% compared to CNY 3,955,189,341.59 in the same period last year[28] - Operating profit for Q3 2022 was CNY 322,901,669.29, down from CNY 991,186,173.20 in Q3 2021, representing a decline of 67.4%[28] - Net profit attributable to shareholders of the parent company for Q3 2022 was CNY 312,818,802.18, compared to CNY 879,353,869.24 in Q3 2021, a decrease of 64.4%[32] - The company reported a comprehensive income total of CNY 266,738,410.89 for Q3 2022, down from CNY 882,754,969.76 in the previous year[32] - Basic and diluted earnings per share for Q3 2022 were both CNY 0.30, compared to CNY 0.98 in Q3 2021, a decline of 69.4%[32] Assets and Liabilities - Total assets increased to ¥16,049,221,257.19, representing a growth of 48.23% compared to the end of the previous year[7] - Total assets reached ¥16,049,221,257.19, an increase from ¥10,827,582,486.33 year-over-year[23] - Current assets totaled ¥8,120,808,499.35, up from ¥3,463,194,933.39 in the previous year[23] - Total liabilities as of Q3 2022 amounted to CNY 3,914,930,109.16, an increase from CNY 3,747,195,020.39 in the previous year[28] - Total equity for Q3 2022 was CNY 12,134,291,148.03, up from CNY 7,080,387,465.94 in the same period last year, reflecting a growth of 71.5%[28] Cash Flow - Cash flow from operating activities for the year-to-date was ¥489,479,421.82, a decrease of 29.38% compared to the same period last year[7] - The net cash flow from operating activities for the current period is ¥489,479,421.82, a decrease of 29.4% compared to ¥693,155,448.92 in the previous period[36] - Total cash inflow from operating activities is ¥2,717,917,997.33, down from ¥3,336,376,002.73, reflecting a decline of 15.5%[36] - Cash outflow from operating activities amounts to ¥2,228,438,575.51, compared to ¥2,643,220,553.81 in the previous period, indicating a decrease of 15.7%[36] - The net cash flow from investing activities is -¥441,570,432.59, an improvement from -¥1,414,166,936.24 in the previous period[36] - Cash inflow from investing activities totals ¥240,840,804.85, significantly higher than ¥75,269,790.65 in the previous period[36] - Cash outflow from investing activities is ¥682,411,237.44, down from ¥1,489,436,726.89, showing a reduction of 54.3%[36] - The net cash flow from financing activities is ¥4,849,283,907.29, compared to ¥147,458,507.84 in the previous period, indicating a substantial increase[36] - Total cash inflow from financing activities is ¥5,759,469,664.32, up from ¥1,658,267,776.11, reflecting a growth of 247.5%[36] - The net increase in cash and cash equivalents for the current period is ¥4,904,955,874.43, contrasting with a decrease of ¥574,053,576.42 in the previous period[39] - The ending balance of cash and cash equivalents is ¥6,110,736,870.06, significantly higher than ¥1,377,797,173.85 in the previous period[39] Shareholder Information - The number of common shareholders at the end of the reporting period was 118,559, with the largest shareholder holding 23.12%[16] Expenses and Financial Costs - Research and development expenses for Q3 2022 were CNY 162,880,362.86, slightly up from CNY 161,760,743.96 in Q3 2021[28] - Financial expenses rose significantly by 639.47% to -¥97,062,253.39, attributed to increased interest income from raised funds[15] - The company’s financial costs showed a significant improvement, with a net financial cost of -CNY 97,062,253.39 in Q3 2022, compared to -CNY 13,125,911.41 in Q3 2021[28] - Investment income dropped by 66.28% to ¥37,760,769.95, mainly due to dilution of control in subsidiaries[15]